MICHELLE LEWIS: Open Payments
NPI 1205235678 · NY, NY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$80 in 4 payments from 4 companies in 2025. Trend: 2023 $258 · 2024 $290 · 2025 $80
Food & beverage: $80
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Coherus Oncology, Inc. | 1 | $20 |
| Celgene Corporation | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: GLASSIA, LOQTORZI, REBLOZYL, TEZSPIRE.
Industry payments across NY — which companies pay providers there.
